Log in

NYSE:BDXBecton Dickinson and Stock Price, Forecast & News

$257.22
+2.22 (+0.87 %)
(As of 08/13/2020 04:00 PM ET)
Add
Compare
Today's Range
$255.89
Now: $257.22
$259.54
50-Day Range
$228.94
MA: $259.73
$283.68
52-Week Range
$197.75
Now: $257.22
$286.72
Volume1.22 million shs
Average Volume2.06 million shs
Market Capitalization$74.56 billion
P/E Ratio92.53
Dividend Yield1.23%
Beta0.98
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company's BD Medical segment offers peripheral IV and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, IV fluids, closed-system drug transfer devices, hazardous drug detection, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, sharps disposal systems; infusion pumps and dedicated disposables, medication compounding workflow systems, automated medication dispensing, automated supply management systems, medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes care; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products and systems; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, monoclonal antibodies and kits, reagent systems, bench-side solutions, and molecular indexing and next-generation sequencing sample preparation products, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, thoracic and abdominal drainage, and surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. Becton, Dickinson and Company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Read More
Becton Dickinson and logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.3Dividend Strength: 3.3Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.23 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP07588710
Phone201-847-6800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$17.29 billion
Cash Flow$20.81 per share
Book Value$82.86 per share

Profitability

Net Income$1.23 billion

Miscellaneous

Employees70,093
Market Cap$74.56 billion
Next Earnings Date11/3/2020 (Estimated)
OptionableOptionable
$257.22
+2.22 (+0.87 %)
(As of 08/13/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BDX News and Ratings via Email

Sign-up to receive the latest news and ratings for BDX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Becton Dickinson and (NYSE:BDX) Frequently Asked Questions

How has Becton Dickinson and's stock price been impacted by COVID-19 (Coronavirus)?

Becton Dickinson and's stock was trading at $231.91 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, BDX stock has increased by 10.9% and is now trading at $257.22.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Becton Dickinson and?

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Becton Dickinson and in the last year. There are currently 7 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Becton Dickinson and
.

When is Becton Dickinson and's next earnings date?

Becton Dickinson and is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for Becton Dickinson and
.

How were Becton Dickinson and's earnings last quarter?

Becton Dickinson and Co (NYSE:BDX) posted its quarterly earnings results on Thursday, August, 6th. The medical instruments supplier reported $2.20 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $2.04 by $0.16. The medical instruments supplier had revenue of $3.86 billion for the quarter, compared to the consensus estimate of $3.96 billion. Becton Dickinson and had a net margin of 5.30% and a return on equity of 14.19%. Becton Dickinson and's revenue for the quarter was down 11.4% on a year-over-year basis. During the same quarter last year, the company posted $3.08 EPS.
View Becton Dickinson and's earnings history
.

How often does Becton Dickinson and pay dividends? What is the dividend yield for Becton Dickinson and?

Becton Dickinson and announced a quarterly dividend on Monday, July 27th. Shareholders of record on Wednesday, September 9th will be given a dividend of $0.79 per share on Wednesday, September 30th. This represents a $3.16 annualized dividend and a dividend yield of 1.23%. The ex-dividend date of this dividend is Tuesday, September 8th.
View Becton Dickinson and's dividend history
.

What guidance has Becton Dickinson and issued on next quarter's earnings?

Becton Dickinson and issued an update on its FY20 earnings guidance on Thursday, August, 6th. The company provided earnings per share (EPS) guidance of $9.80-10.00 for the period, compared to the Thomson Reuters consensus estimate of $10.38. The company issued revenue guidance of decline of 2.5-3.0% to $16.83-16.92 billion, compared to the consensus revenue estimate of $17.00 billion.

What price target have analysts set for BDX?

15 brokerages have issued 12-month target prices for Becton Dickinson and's shares. Their forecasts range from $260.00 to $300.00. On average, they expect Becton Dickinson and's share price to reach $283.00 in the next year. This suggests a possible upside of 10.0% from the stock's current price.
View analysts' price targets for Becton Dickinson and
.

Has Becton Dickinson and been receiving favorable news coverage?

News headlines about BDX stock have been trending negative recently, InfoTrie Sentiment reports. The research group scores the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Becton Dickinson and earned a news impact score of -2.4 on InfoTrie's scale. They also assigned media headlines about the medical instruments supplier a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term.
View the latest news about Becton Dickinson and
.

Are investors shorting Becton Dickinson and?

Becton Dickinson and saw a drop in short interest in May. As of May 15th, there was short interest totaling 2,240,000 shares, a drop of 64.5% from the April 30th total of 6,310,000 shares. Based on an average daily trading volume, of 2,510,000 shares, the short-interest ratio is presently 0.9 days.
View Becton Dickinson and's Short Interest
.

Who are some of Becton Dickinson and's key competitors?

What other stocks do shareholders of Becton Dickinson and own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Becton Dickinson and investors own include Johnson & Johnson (JNJ), AbbVie (ABBV), AT&T (T), Walt Disney (DIS), Abbott Laboratories (ABT), NVIDIA (NVDA), Verizon Communications (VZ), Cisco Systems (CSCO), Medtronic (MDT) and Chevron (CVX).

Who are Becton Dickinson and's key executives?

Becton Dickinson and's management team includes the following people:
  • Mr. Vincent A. Forlenza, Chairman & CEO (Age 66)
  • Mr. Thomas E. Polen Jr., Pres & COO (Age 46)
  • Mr. Christopher R. Reidy, Exec. VP, CFO & Chief Admin. Officer (Age 62)
  • Mr. Samrat S. Khichi, Exec. VP & Gen. Counsel (Age 52)
  • Mr. Patrick K. Kaltenbach, Exec. VP & Pres of the Life Sciences Segment (Age 56)

What is Becton Dickinson and's stock symbol?

Becton Dickinson and trades on the New York Stock Exchange (NYSE) under the ticker symbol "BDX."

Who are Becton Dickinson and's major shareholders?

Becton Dickinson and's stock is owned by a number of institutional and retail investors. Top institutional shareholders include FMR LLC (4.26%), Bank of New York Mellon Corp (1.01%), Cantillon Capital Management LLC (0.45%), Principal Financial Group Inc. (0.43%), Swiss National Bank (0.42%) and Sumitomo Mitsui Trust Holdings Inc. (0.41%). Company insiders that own Becton Dickinson and stock include Alexandre Conroy, Betty D Larson, Catherine M Burzik, Charles R Bodner, Claire Fraser, James C Lim, James W Borzi, Patrick Kaltenbach, Ribo Alberto Mas, Roland Goette, Samrat S Khichi, Simon D Campion, Thomas E Polen Jr, Thomas J Spoerel, Timothy M Ring and Vincent A Forlenza.
View institutional ownership trends for Becton Dickinson and
.

Which institutional investors are selling Becton Dickinson and stock?

BDX stock was sold by a variety of institutional investors in the last quarter, including Cooke & Bieler LP, CIBC Private Wealth Group LLC, Toronto Dominion Bank, DekaBank Deutsche Girozentrale, Waverton Investment Management Ltd, Grantham Mayo Van Otterloo & Co. LLC, WASHINGTON TRUST Co, and Montag & Caldwell LLC. Company insiders that have sold Becton Dickinson and company stock in the last year include Alexandre Conroy, Charles R Bodner, Claire Fraser, James C Lim, Patrick Kaltenbach, Ribo Alberto Mas, Simon D Campion, Thomas J Spoerel, and Vincent A Forlenza.
View insider buying and selling activity for Becton Dickinson and
.

Which institutional investors are buying Becton Dickinson and stock?

BDX stock was purchased by a variety of institutional investors in the last quarter, including FMR LLC, Bank of New York Mellon Corp, Principal Financial Group Inc., Retirement Systems of Alabama, Cibc World Markets Corp, State of Wisconsin Investment Board, LA Financiere DE L Echiquier, and Rathbone Brothers plc.
View insider buying and selling activity for Becton Dickinson and
.

How do I buy shares of Becton Dickinson and?

Shares of BDX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Becton Dickinson and's stock price today?

One share of BDX stock can currently be purchased for approximately $257.22.

How big of a company is Becton Dickinson and?

Becton Dickinson and has a market capitalization of $74.56 billion and generates $17.29 billion in revenue each year. The medical instruments supplier earns $1.23 billion in net income (profit) each year or $11.68 on an earnings per share basis. Becton Dickinson and employs 70,093 workers across the globe.

What is Becton Dickinson and's official website?

The official website for Becton Dickinson and is www.bd.com.

How can I contact Becton Dickinson and?

Becton Dickinson and's mailing address is 1 BECTON DRIVE, FRANKLIN LAKES NJ, 07417. The medical instruments supplier can be reached via phone at 201-847-6800.

This page was last updated on 8/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.